Ginkgo Bioworks Holdings (NYSE: DNA) has undoubtedly been a standout performer in the dynamic biotech sector this week, showcasing its resilience and potential. The company’s stock price has experienced a remarkable 34% surge, sending ripples of excitement throughout the market. What triggered this ...